A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : RVNA / rabies virus neutralizing antibody

[Related PubMed/MEDLINE]
Total Number of Papers: 73
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   RVNA  (>> Co-occurring Abbreviation)
Long Form:   rabies virus neutralizing antibody
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Factors influencing the immune response after a double-dose 2-visit pre-exposure rabies intradermal vaccination schedule: A retrospective study. PrEP, WHO
2020 Immunogenicity of Ontario Rabies Vaccine for Small Indian Mongooses (Herpestes auropunctatus). ONRAB, PV
2020 Purified Vero Cell Rabies Vaccine (PVRV, Verorab): A Systematic Review of Intradermal Use Between 1985 and 2019. ID, PEP, PrEP, PVRV
2020 Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial. CI, HRIG
2020 Severe multiple rabid dog bite injuries in a child in central China: Continuous 10-year observation and analysis on this case. PEP
2020 Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines. ERIG, GMTs, ID, PEP, RFFIT, TRC
2020 The Serological Prevalence of Rabies Virus-Neutralizing Antibodies in the Bat Population on the Caribbean Island of Trinidad. RABV
2019 A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies. RFFIT, rRV-GFP
2019 A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children. ---
10  2019 Assessment of naturally acquired neutralizing antibodies against rabies Lyssavirus in a subset of Nunavik's Inuit population considered most at risk of being exposed to rabid animals. ---
11  2019 Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception. GnRH
12  2019 Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. ID, PEP, pERIG, PVRV, RIG, TRC
14  2019 Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus. DEAE, GCLP, ICH, RFFIT, SRIGs, WHO
15  2019 Timing of Intradermal Rabies Pre-exposure Prophylaxis Injections: Immunological Effect on Vaccination Response. ID, PrEP
16  2018 Adjuvant activity of ethanol extract of Hippophae rhamnoides leaves with inactivated rabies virus antigen. CTLs, Rb, SBT, SBTE
17  2018 Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study. CI, GMC, HRIG, PEP, RIG
18  2018 Immunogenic response in obese patients undergoing rabies post-exposure prophylaxis with combined equine rabies immunoglobulin and rabies vaccination. GMT, RIG
19  2018 Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis. ID, IM, PCECV, PEP, WHO
20  2018 Raccoon (Procyon lotor) biomarker and rabies antibody response to varying oral rabies vaccine bait densities in northwestern Pennsylvania. ---
21  2018 Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. CI, HRIG, PCECV, PEP, TRC
22  2017 A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen. control-classic, PIKA-accelerated
23  2017 An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. AEs, PEP, TLR3
24  2017 Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies. RFFIT
25  2017 Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study. AEs, PCECV
26  2017 Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines. IRV, LipoRV, WHO
27  2017 Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida. ORV
28  2017 Rabies Virus Exposure of Brazilian Free-ranging Wildlife from Municipalities without Clinical Cases in Humans or in Terrestrial Wildlife. RFFIT
29  2017 Single visit rabies pre-exposure priming induces a robust anamnestic antibody response after simulated post-exposure vaccination: results of a dose-finding study. ID, IM
30  2016 Duration of serum antibody response to rabies vaccination in horses. ---
31  2016 One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series. JE, PrEP
32  2016 Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil. EU, IU, PEP, PrEP, PVRV
33  2016 Rabies vaccine response measurement is assay dependent. ELISA, SN
34  2015 A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies. RVG
35  2015 Antibody response of cattle to vaccination with commercial modified live rabies vaccines in Guatemala. RFFIT
36  2015 Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes. ELISPOT, IFN-gamma, IL-4
37  2015 Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). PCECV, PEP, RFFIT
38  2015 Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. CTRI
39  2015 Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. AEs, IM, PCECV, PEP
40  2014 A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. PCECV, PVRV
41  2014 Development and evaluation of a new immunohistochemistry-based test for the detection of rabies virus neutralizing antibodies. FAVN, LLOQ, RFFIT
42  2014 Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG. ADEM, HRIG, PCECV, PVRV
43  2014 Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer. BHK, PETIM
44  2014 Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant. MyD88, pIRES-Rgp
45  2014 Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB, an adenovirus-rabies recombinant vaccine. ---
46  2014 Utility of real-time Taqman PCR for antemortem and postmortem diagnosis of human rabies. RFFIT
47  2014 Variability in seroprevalence of rabies virus neutralizing antibodies and associated factors in a Colorado population of big brown bats (Eptesicus fuscus). ---
48  2013 A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab when administered according to a post-exposure regimen in healthy children and adults in China. RITA
49  2013 A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial. FAS
50  2013 Establishment and preliminary application of a rapid fluorescent focus inhibition test (RFFIT) for rabies virus. PCECV, PVRV, RFFIT, WHO
51  2013 Humoral immune response to oral rabies vaccination in raccoon kits: problems and implications. V-RG
52  2013 Prevalence of neutralizing antibodies to rabies virus in serum of seven species of insectivorous bats from Colorado and New Mexico, United States. ---
53  2013 Rabid fox bites and human rabies in a village community in southern India: epidemiological and laboratory investigations, management and follow-up. FAT, PCEC
54  2012 Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. PVRV, RFFIT
55  2012 Mucosal adjuvants to improve wildlife rabies vaccination. ORV, TMC
56  2011 Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren. ID, PrEP
57  2010 Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines when administered by intradermal route: results of a metaanalysis. MNT, RFFIT
58  2008 An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax) in Indian subjects. ---
59  2008 First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. PEP
60  2008 Oral rabies vaccination of a northern Ohio raccoon population: relevance of population density and prebait serology. ORV, VBU
61  2008 Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). PCECV, PVRV
62  2007 Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. PCECV
63  2006 Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. ID, PCECV, PVRV, RFFIT, TRC
64  2006 Detection of cellular immunity to rabies antigens in human vaccinees. ---
65  2006 Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. ID, PCECV, PEP, PVRV, RFFIT, TRC
66  2005 Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis. ---
67  2005 DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. CMV, RVG, SS, TD, tPA
68  2005 Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. AEs, ID, KIMS, PCECV, PEP
69  2004 Vaccination of Egyptian fruit bats (Rousettus aegyptiacus) with monovalent inactivated rabies vaccine. ---
70  2003 Raccoon poxvirus as a mucosal vaccine vector for domestic cats. CO, i.n, IN/CO, RCN
71  2001 Antibody response to rabies vaccination in captive and free-ranging wolves (Canis lupus). PV
72  2001 Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine. CRV, DRV
73  1999 Immunization of dogs and cats with a DNA vaccine against rabies virus. ID, IM